Drug Pipeline

Modafinil Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
2
Recruiting
3
Phase 3
5
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-04 NCT06404099
RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)		 Trial completed
Active Studies by Phase
Phase 3
2
Phase 2/3
1
Phase 1/2
1
Early Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07231497 Cognitive Strategies in Early Psychosis 1 Cognition Recruiting
NCT07263022 Cognitive Strategies in Early Psychosis 2 Psychosis Not Yet Recruiting
Phase 2/3
NCT07582458 Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD… Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) Not Yet Recruiting
Phase 1/2
NCT05333250 Modafinil to Improve Fatiguability Cancer-related Cognitive Difficulties Recruiting
Early Phase 1
NCT01988883 Modafinil and Cognitive Function in POTS Postural Tachycardia Syndrome Active, Not Recruiting
Not specified
NCT07568574 Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes Enrolling by Invitation
Sponsors Running Modafinil Trials
University of Minnesota (2) Vanderbilt University Medical Center (1) Ottawa Hospital Research Institute (1) Enhanced Emirates Limited (1) Radboud University Medical Center (1)
Disease Areas
Depression (1) Bipolar Disorder (1) Schizophrenia (1) Ulcerative Colitis (1)
Get alerts when Modafinil trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free